Cytochrome P450 activity and endothelial dysfunction in insulin resistance.

Area of Science:

• Vascular Biology
• Metabolic Syndrome
• Pharmacology

Background:

• Insulin resistance impairs endothelium-dependent relaxation via endothelium-dependent hyperpolarizing factor (EDHF) in small mesenteric arteries.
• The role of cytochrome P450 enzymes in this dysfunction is not fully understood.

Purpose of the Study:

• To investigate if modulating cytochrome P450 activity can restore EDHF-mediated relaxation in insulin-resistant rats.
• To assess the impact of cytochrome P450 inhibition and induction on vascular function and blood pressure.

Main Methods:

• Sprague-Dawley rats were divided into control and insulin-resistant groups.
• Groups received miconazole (P450 inhibition) or phenobarbital (P450 induction) or placebo.
• Vascular function was assessed in small mesenteric arteries using acetylcholine-induced relaxation, with and without inhibitors.

Main Results:

• Miconazole impaired relaxation in control rats but not in insulin-resistant rats.
• Phenobarbital treatment significantly improved acetylcholine-induced relaxation in insulin-resistant arteries.
• Phenobarbital normalized mean arterial pressure in insulin-resistant rats, while miconazole increased it in controls.

Conclusions:

• Cytochrome P450 induction, achieved with phenobarbital, restores EDHF-mediated relaxation in insulin-resistant rat mesenteric arteries.
• Induction of cytochrome P450 can reverse endothelial dysfunction associated with insulin resistance.
• Modulating cytochrome P450 activity offers a potential therapeutic strategy for insulin resistance-related vascular complications.